2nd Quarter - Report

FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (no bill) issues related to veteran health care coverage (no bill); issues related to military health care coverage (no bill); issues related to Medicare physician fee schedule and Orphan Cures (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).

LobbyistCovered position, as disclosed
TEGAN GELFAND —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1 (119th), H.Con.Res. 14 (119th)

Taxation/Internal Revenue Code TAX

Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill); issues related to taxation of foreign businesses (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).

LobbyistCovered position, as disclosed
TEGAN GELFAND —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1878 (119th), H.Con.Res. 14 (119th), H.R. 1 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.